STRS Ohio’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

STRS Ohio’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-35,300	Closed	-$972K	–	2371
2021 Q2	$972K	Buy	35,300 +3,400	+11%	+$66.8K	﹤0.01%	1187
2021 Q1	$526K	Sell	31,900 -2,700	-8%	-$61.5K	﹤0.01%	1551
2020 Q4	$637K	Buy	34,600 +22,400	+184%	+$401K	﹤0.01%	1349
2020 Q3	$166K	Hold	12,200	–	–	﹤0.01%	1719
2020 Q2	$218K	Buy	+12,200	New	+$184K	﹤0.01%	1616
2019 Q2	–	Sell	-2,800	Closed	-$28K	–	2251
2019 Q1	$28K	Hold	2,800	–	–	﹤0.01%	1943
2018 Q4	$21K	Hold	2,800	–	–	﹤0.01%	1988
2018 Q3	$28K	Buy	+2,800	New	+$32.6K	﹤0.01%	2008

STRS Ohio's TBIO Position: Q3 2021 in Review

STRS Ohio sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 35,300 shares — an estimated $972K sold.

STRS Ohio first reported a position in TBIO in Q3 2018 and held it in 8 quarters. The position peaked at $972K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

STRS Ohio reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
STRS Ohio sold 35,300 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $972K.
STRS Ohio first reported a position in Translate Bio, Inc. Common Stock in Q3 2018 and held it in 8 quarters.
STRS Ohio's Translate Bio, Inc. Common Stock position peaked at $972K in Q2 2021.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on STRS Ohio's 13F filing for Q3 2021, filed 22 Oct 2021.